Table of Contents
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Pneumonia Therapeutics Market, by Region, 2019-2029 (USD Billion)
1.2.2. Pneumonia Therapeutics Market, by Therapeutics, 2019-2029 (USD Billion)
1.2.3. Pneumonia Therapeutics Market, by Distribution Channel, 2019-2029 (USD Billion)
1.2.4. Pneumonia Therapeutics Market, by Age Group, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Pneumonia Therapeutics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Pneumonia Therapeutics Market Dynamics
3.1. Pneumonia Therapeutics Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing incidences of Pneumonia
3.1.1.2. Growing unmet clinical needs
3.1.1.3. Strategic initiatives from leading market players.
3.1.2. Market Challenges
3.1.2.1. High treatment cost.
3.1.2.2. Lack of awareness towards preventive vaccines.
3.1.3. Market Opportunities
3.1.3.1. Rising healthcare spending in developing regions.
3.1.3.2. Growing number of R&D activities in pharmaceuticals sector.
Chapter 4. Global Pneumonia Therapeutics Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Pneumonia Therapeutics Market, by Therapeutics
6.1. Market Snapshot
6.2. Global Pneumonia Therapeutics Market by Therapeutics, Performance - Potential Analysis
6.3. Global Pneumonia Therapeutics Market Estimates & Forecasts by Therapeutics 2019-2029 (USD Billion)
6.4. Pneumonia Therapeutics Market, Sub Segment Analysis
6.4.1. Prevention Vaccines
6.4.2. Treatment Drugs
Chapter 7. Global Pneumonia Therapeutics Market, by Distribution Channel
7.1. Market Snapshot
7.2. Global Pneumonia Therapeutics Market by Distribution Channel, Performance - Potential Analysis
7.3. Global Pneumonia Therapeutics Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
7.4. Pneumonia Therapeutics Market, Sub Segment Analysis
7.4.1. Hospitals
7.4.2. Pharmaceutical Stores
7.4.3. Others
Chapter 8. Global Pneumonia Therapeutics Market, by Age Group
8.1. Market Snapshot
8.2. Global Pneumonia Therapeutics Market by Age Group, Performance - Potential Analysis
8.3. Global Pneumonia Therapeutics Market Estimates & Forecasts by Age Group 2019-2029 (USD Billion)
8.4. Pneumonia Therapeutics Market, Sub Segment Analysis
8.4.1. Pediatric
8.4.2. Adult
8.4.3. Geriatric
Chapter 9. Global Pneumonia Therapeutics Market, Regional Analysis
9.1. Pneumonia Therapeutics Market, Regional Market Snapshot
9.2. North America Pneumonia Therapeutics Market
9.2.1. U.S. Pneumonia Therapeutics Market
9.2.1.1. Therapeutics breakdown estimates & forecasts, 2019-2029
9.2.1.2. Distribution Channel breakdown estimates & forecasts, 2019-2029
9.2.1.3. Age Group breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Pneumonia Therapeutics Market
9.3. Europe Pneumonia Therapeutics Market Snapshot
9.3.1. U.K. Pneumonia Therapeutics Market
9.3.2. Germany Pneumonia Therapeutics Market
9.3.3. France Pneumonia Therapeutics Market
9.3.4. Spain Pneumonia Therapeutics Market
9.3.5. Italy Pneumonia Therapeutics Market
9.3.6. Rest of Europe Pneumonia Therapeutics Market
9.4. Asia-Pacific Pneumonia Therapeutics Market Snapshot
9.4.1. China Pneumonia Therapeutics Market
9.4.2. India Pneumonia Therapeutics Market
9.4.3. Japan Pneumonia Therapeutics Market
9.4.4. Australia Pneumonia Therapeutics Market
9.4.5. South Korea Pneumonia Therapeutics Market
9.4.6. Rest of Asia Pacific Pneumonia Therapeutics Market
9.5. Latin America Pneumonia Therapeutics Market Snapshot
9.5.1. Brazil Pneumonia Therapeutics Market
9.5.2. Mexico Pneumonia Therapeutics Market
9.6. Rest of The World Pneumonia Therapeutics Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Abbott Laboratories
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Bayer AG
10.2.3. Eli Lilly & Company
10.2.4. GlaxoSmithKline PLC.
10.2.5. Lupin Pharmaceuticals, Inc.
10.2.6. Merck KGAA
10.2.7. Novartis AG
10.2.8. Pfizer, Inc.
10.2.9. Sanofi S.A.
10.2.10. Teva Pharmaceuticals Industries Limited.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption